Starting insulin icodec in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests different ways to start a new long-acting insulin called icodec for people with type 2 diabetes. It looks at how to give an extra dose on day 4 to help control blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had type 2 diabetes for at least 6 months.
- You have not taken any insulin in the last 3 months.
- You are currently taking at least one diabetes pill or a GLP-1 medicine but your blood sugar is still not well controlled.
- Your most recent A1c test is between 7.0% and 11.0%.
- You are willing to wear a continuous glucose monitor and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests how well different diabetes medications work after a brief period of intensive insulin therapy. It may help you find a simpler, effective treatment plan tailored to your needs.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
This study looks at how well once-weekly insulin icodec controls blood sugar and improves quality of life for people with type 2 diabetes who currently take daily insulin injections. You'll switch from your daily insulin to a once-weekly injection and the study will track your blood sugar control, treatment satisfaction, and how well you stick with the new schedule.
This study tests a new once-weekly insulin shot (icodec) compared to daily long-acting insulins for people with type 2 diabetes whose blood sugar is not well controlled on their current non-insulin medications.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.